Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two HIFs may be better than one.

Tiffany Seagroves1, Randall S Johnson

  • 1Molecular Biology Section, Division of Biology, University of California, San Diego, La Jolla 92093, USA.

Cancer Cell
|June 28, 2002
PubMed
Summary
This summary is machine-generated.

Overexpression of hypoxia-inducible factor-2 alpha (HIF-2alpha) drives kidney clear cell cancer development. This research demonstrates HIF-2alpha

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-unstable mRNAs in activated CD8<sup>+</sup> T cells are defined by interlinked AU-rich elements and m<sup>6</sup>A mRNA methylation.

Nature communications·2026
Same author

Lipoyl deglutarylation by ABHD11 regulates mitochondrial and T cell metabolism.

Nature chemical biology·2025
Same author

A 2-hydroxybutyrate-mediated feedback loop regulates muscular fatigue.

eLife·2024
Same author

The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy.

Frontiers in immunology·2024
Same author

A century of the Warburg effect.

Nature metabolism·2023
Same author

The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function.

Cell reports·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Renal Cell Carcinoma Research

Background:

  • Investigating the role of hypoxia-inducible factors (HIFs) in cancer development.
  • Understanding the specific contribution of HIF-2alpha to renal clear cell tumorigenesis.

Discussion:

  • HIF-2alpha acts as a direct driver in the initiation of renal clear cell tumors.
  • Evidence supports the classification of HIF-2alpha as a tumor promoter in kidney cancer.

Key Insights:

  • Direct causal link established between HIF-2alpha overexpression and clear cell renal cell carcinoma.
  • Demonstrates the oncogenic potential of HIF-2alpha in the kidney.

Outlook:

  • Potential therapeutic strategies targeting HIF-2alpha for renal clear cell carcinoma.
  • Further research into HIF pathway modulation for cancer treatment.